Regener8 Annual Conference

Regener8 Annual Conference

17-09-2014 University of LeedsLeeds, UK

Now in its seventh year, the Regener8 Annual Conference provides an opportunity for companies, many of whom are start-ups or SMEs, to share experiences and best practice in taking innovative and highly-specialised regenerative therapies to market.

Now in its seventh year, the Regener8 Annual Conference provides an opportunity for companies, many of whom are start-ups or SMEs, to share experiences and best practice in taking innovative and highly-specialised regenerative therapies to market.

Innovators specialising in the rapidly emerging field of Regenerative Medicine will gather in Leeds in September to discuss how the latest research is being translated into clinical benefits for patients.

 The Regener8 Annual Conference, which will take place on 17 September at the University of Leeds, will focus on ‘The Pathway to Innovation for Regenerative Therapies’ and will feature some of the latest research being carried out in areas as diverse as bio-cements for bone regeneration, cellular scaffolds for cardiac repair and regenerative therapies for dental repair.

 Hosted by the University of Leeds, and working in partnership with the Medical Technologies IKC – also based in Leeds – Regener8 brings together leading academics, industry and clinicians to nurture innovation in regenerative medicine, and translate academic research into products that can be used by clinicians and patients. Regenerative medicine (‘RegenMed’) is being used to treat conditions such as diabetes, heart disease, bone fractures, chronic wound management and many others by augmenting or stimulating the body's own repair mechanisms to repair or replace damaged tissue. It is one of the ‘Eight Great Technologies’ highlighted by the Government as priorities for investment.

Back to top